Steris Corp.
Medtronic-Covidien merger may get caught in anti-inversion legislation | Medtech legal news for the week of July 21, 2014
Steris, Medtrica win legal fees in Cygnus Medical patent spat
FDA warns Steris Isomedix on QA, data manipulation issues
Steris closes $165M IMS buy, takes $20.5M charge for restructuring in Q4
Steris offers $165M for Integrated Medical Systems
Steris to lay off 150, close Ohio plant
Zynex CEO clears out board | Personnel Moves
Zynex (OTC:ZYXI) CEO Thomas Sandgaard has cleared the path to reshape the company after cutting its board in half.
Sandgaard asked for the resignations of board members Mats Wahlstrom, Mary Beth Vitale, Kevin Smith and Taylor Simonton, to add board members who share Sandgaard’s vision for the rehab devices maker.
European restructuring costs hit Q1 earnings for Steris
Steris posts a mixed bag in Q1, strong sales and earnings offset by restructuring costs and per-share earnings that miss expectations by 1 cent.
Steris (NYSE:STE) took a hit during its fiscal 1st quarter from a $9.2 million tax charge over its restructuring in Europe, but posted a more than 9% top-line gain.